First Horizon Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.3K | Buy |
1,195
+862
| +259% | +$17.5K | ﹤0.01% | 1337 |
|
|
2025
Q1 | $6.04K | Hold |
333
| – | – | ﹤0.01% | 1763 |
|
|
2024
Q4 | $8.41K | Hold |
333
| – | – | ﹤0.01% | 1657 |
|
|
2024
Q3 | $11.3K | Hold |
333
| – | – | ﹤0.01% | 1569 |
|
|
2024
Q2 | $12.3K | Hold |
333
| – | – | ﹤0.01% | 1447 |
|
|
2024
Q1 | $14K | Hold |
333
| – | – | ﹤0.01% | 1469 |
|
|
2023
Q4 | $13.2K | Hold |
333
| – | – | ﹤0.01% | 1488 |
|
|
2023
Q3 | $9.16K | Hold |
333
| – | – | ﹤0.01% | 1544 |
|
|
2023
Q2 | $11.3K | Hold |
333
| – | – | ﹤0.01% | 1496 |
|
|
2023
Q1 | $12K | Hold |
333
| – | – | ﹤0.01% | 1484 |
|
|
2022
Q4 | $14.8K | Hold |
333
| – | – | ﹤0.01% | 1376 |
|
|
2022
Q3 | $9K | Hold |
333
| – | – | ﹤0.01% | 1539 |
|
|
2022
Q2 | $9K | Hold |
333
| – | – | ﹤0.01% | 1615 |
|
|
2022
Q1 | $11K | Hold |
333
| – | – | ﹤0.01% | 1069 |
|
|
2021
Q4 | $13K | Hold |
333
| – | – | ﹤0.01% | 1434 |
|
|
2021
Q3 | $18K | Buy |
+333
| New | +$18K | ﹤0.01% | 1315 |
|